Wilkinson Peter J

SVP, Chief Accounting Officer at LH; VP of Fin./Chief Acctg. Off. at PHARMACEUTICAL PRODUCT DEVELOPMENT INC

Sold, on record
$4M
Dollars the filings state
Form 4 sales
13
Latest Aug 3, 2026
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

2
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LHUnusual
    Nov 16, 2023 2023

    Sold 1,384 shares at $210.71 ($292k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 39.9% of holdings ($731k position)2,087 shares leftFiling

  2. 2 Form 4 sale LHUnusual
    Apr 29, 2024 +165 days

    Sold 2,439 shares at $204.33 ($498k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 53.9% of holdings ($925k position)2,087 shares leftFiling

  3. 3 Form 4 sale LHUnusual
    Feb 18, 2025 +295 days

    Sold 1,413 shares at $246.10 ($348k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 41.5% of holdings ($838k position)1,993 shares leftFiling

  4. 4 Form 4 sale LHUnusual
    May 1, 2025 +72 days

    Sold 829 shares at $242.27 ($201k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 28.8% of holdings ($699k position)2,054 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale LHNo plan
    Jul 29, 2025 +89 days

    Sold 202 shares at $261.02 ($53k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 9.8% of holdings ($536k position)1,852 shares left0.1x usual sizeFiling

  6. 6 Form 4 sale LHRoutine
    Feb 19, 2026 +205 days

    Sold 666 shares at $277.94 ($185k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    10b5-1 planSold 26.4% of holdings ($700k position)1,852 shares left0.6x usual sizeFiling

  7. 7 Form 4 sale LHRoutine
    Mar 27, 2026 +36 days

    Sold 1,633 shares at $267.05 ($436k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    10b5-1 planSold 46.9% of holdings ($931k position)1,852 shares left2x usual sizeFiling

  8. 8 Form 4 sale LHUnusual
    Aug 3, 2026 +129 days

    Sold 1,420 shares at $309.23 ($439k)

    Wilkinson Peter J, SVP, Chief Accounting Officer

    No 10b5-1 planSold 44.5% of holdings ($987k position)1,770 shares left1.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Wilkinson Peter J
Source
Aug 3, 2026Aug 5, 2026LHSVP, Chief Accounting OfficerForm 4 sale1,420$439k44.5%UnusualSEC
Mar 27, 2026Mar 30, 2026LHSVP, Chief Accounting OfficerForm 4 sale1,633$436k46.9%RoutineSEC
Feb 19, 2026Feb 23, 2026LHSVP, Chief Accounting OfficerForm 4 sale666$185k26.4%RoutineSEC
Jul 29, 2025Jul 31, 2025LHSVP, Chief Accounting OfficerForm 4 sale202$53k9.8%No planSEC
May 1, 2025May 5, 2025LHSVP, Chief Accounting OfficerForm 4 sale829$201k28.8%UnusualSEC
Feb 18, 2025Feb 20, 2025LHSVP, Chief Accounting OfficerForm 4 sale1,413$348k41.5%UnusualSEC
Apr 29, 2024May 1, 2024LHSVP, Chief Accounting OfficerForm 4 sale2,439$498k53.9%UnusualSEC
Nov 16, 2023Nov 20, 2023LHSVP, Chief Accounting OfficerForm 4 sale1,384$292k39.9%UnusualSEC
Aug 1, 2022Aug 3, 2022LHSVP, Chief Accounting OfficerForm 4 sale2,576$666k57.7%UnusualSEC
Feb 18, 2021Feb 19, 2021LHSVP, Chief Accounting OfficerForm 4 sale2,317$560k87.1%UnusualSEC
Feb 21, 2020Feb 25, 2020LHSVP, Chief Accounting OfficerForm 4 sale297$56k50.0%UnusualSEC
Nov 27, 2007Nov 28, 2007PHARMACEUTICAL PRODUCT DEVELOPMENT INCVP of Fin./Chief Acctg. Off.Form 4 sale6,000$252k100.0%UnusualSEC
Aug 17, 2007Aug 17, 2007PHARMACEUTICAL PRODUCT DEVELOPMENT INCVP of Fin./Chief Acctg. Off.Form 4 sale1,287$47k100.0%UnusualSEC